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Binding of R phage cro repressor to the synthetic half of 0R3, the most conservative half of the specific 
binding sites, was investigated by proton nuclear magnetic resonance spectroscopy. It was found that the 
or-helical segment (27-36) of the protein was involved in specific interactions with the model binding site. 
The 3-dimensional structure of cro repressor does not change noticeably upon complex formation. Interca- 
lation can be excluded as a possible means of interaction. 
cro repressor Protein structure Operator Specljk binding ‘Ii NiUR 
1. INTRODUCTION repressor [8-lo] and its interactions with DNA 
[lO,ll]. 
The regulatory system of A bacteriophage is 
composed of two repressors, cro and cI, whose in- 
teraction with operator sites in the genome deter- 
mines whether phage growth will be lytic or 
lysogenic [l-4]. A study of this system will help us 
gain a better insight into both the regulation of 
gene activity and the molecular mechanisms of 
specific interactions between nucleic acids and 
proteins. 
Here, we report on some structural 
characteristics of the complex of cro repressor pro- 
tein with the synthetic half of 0~3: d(TAT- 
CACCGC) - d(ATAGTGGCG). 
In the A phage genome this sequence occurs in 4 
out of 6 operator sites, for which cro repressor has 
a different affinity [3]. 
The 3-dimensional structures of cro repressor [S] 
and the N-terminal half of c1 repressor [6] deter- 
mined by X-ray diffraction analysis show a high 
degree of homology in the DNA-binding regions of 
these proteins [7]. This has made it possible to con- 
struct a model of their interaction with the 
operator sites. 
2. MATERIALS AND METHODS 
NMR spectroscopy is a technique which pro- 
vides direct information about the structure in 
solution. ‘H NMR was recently used to study cro 
Abbreviations: NMR, nuclear magnetic resonance; 
HPLC, high pressure liquid chromatography; DSS, 
sodium 2,2-dimethyl-2-silapentane-SsuIphonate; CD, 
circular dichroism; NOE, nuclear Overhauser 
enhancement 
The oligodeoxynucleotides d(TATCACCGC) 
and d(ATAGTGGCG) were synthesized by the 
triether method in solution [12]. The protective 
groups in the synthesized compounds were re- 
moved by successive treatment with p- 
nitrobenzaldoxime anion, ammonia and SO?70 
acetic acid. The compounds were isolated using 
high performance liquid chromatography (HPLC) 
on a Zorbax-C8 column (9.4 x 250 mm) in a linear 
methanol gradient (IO-25%) in 0.1 M NHdOAc, 
pH 7.0. The desalted samples were passed through 
a column packed with Dowex-Na+. 
The homogeneity of the compounds was con- 
trolled using HPLC on a Zorbax-C8 column 
(4.6 x 250 mm) in a linear acetonitrile gradient 
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(O-25070) in 0.1 M NH.+OAc, pH 7.0. The primary 
structure was proved by the technique of 
nucleotide maps. 
An equimolar mixture of the oligodeox- 
ynucleotides was prepared by titrating a solution 
of one of the compounds with a solution of other 
and by using the hyperchromism of 9 bp duplex, 
i.e., double-stranded DNA, at 254-260 nm. 
Cro repressor was isolated from the overproduc- 
ing Escherichia coli K 802 strain containing 
plasmid pTR 214 [13], in accordance with the pro- 
cedure described elsewhere [8]. 
‘H NMR spectra were recorded with a Bruker 
WH-360 spectrometer (360 MHz) at 20°C. 
3. RESULTS 
The interaction of the cro repressor with the 
duplex was studied at pH 7.0 and ionic strength 
0.1 M NaCl. This ionic strength was required to 
stabilize the 9 bp duplex. Its melting curve ob- 
tained from the CD data showed that no less than 
90% of the DNA was in the B-form of double helix 
under the experimental conditions (L. Min- 
chenkova, unpublished). On the other hand, at 
such a salt concentration the complex remained 
stable. 
Binding with the duplex has a noticeable effect 
on the protein spectrum (fig. 1 and 2). The complex 
formation is accompanied with a considerable 
broadening of the lines. For example, TyrIII 
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Fig.1. The downfield and upfield regions of the ‘H 
NMR spectrum at 360 MHz for cro repressor (A) and 
for its complex with the operator fragment (B). The 
protein concentration is 0.8 mM in a buffer containing 
10 mM Tris-DC1 (pH 7.0), 0.1 M NaCl, 0.1 mM EDTA 
in D20. Chemical shifts are given with respect to the 
DSS signal. 
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Fig.2. The chemical shifts of the aromatic proton 
resonances and ring current shifted methyl resonances of 
cro repressor as a function of the relative concentration 
of the operator fragment [DNA]/[cro]. 
signals become so broad that they cannot be iden- 
tified at a relative concentration of the 9 bp duplex 
greater than 0.4. It is noteworthy that the proton 
signals of DNA bases broaden in a different man- 
ner in the complex, although these signals have 
almost identical intensities and widths in a spec- 
trum of the free DNA duplex (not shown). 
The binding causes a shift of certain signals in- 
cluding those of histidine-35, TyrIII and some ring 
current shifted (RCS) methyl resonances. 
However, the chemical shifts of TyrI, TyrII, PheI 
and RCS-2 remain unchanged. 
The complex remains stable within a pH range 
from 5.5 to 8.2. Only histidine signals are titrated 
in this region (fig.3). As was shown by comparing 
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Fig.3. The titration curves of histidine-35 signals in free 
cro repressor (- - -) and its complex with the operator 
fragment (-). 
titration curves of the protein in complex with the 
9 bp duplex and those of the free repressor, taken 
under identical conditions, the complex formation 
makes the ionization constant change by approx. 
0.7 pH unit and hardly affects the values of 
chemical shifts corresponding to the protonated 
and deprotonated states. 
4. DISCUSSION 
Overall broadening of the lines in the protein 
spectrum upon addition of DNA is indicative of an 
increase of the effective molecular mass, i.e., of 
complex formation. It was confirmed by complete 
dissociation of the complex and normal line widths 
when increasing an ionic strength up to 0.3 M 
NaCI. Selective broadening of the DNA signals in 
the spectrum of the complex suggests that the com- 
plex is the specific one. 
At the same time, a non-specific interaction with 
DNA [lo] led to broadening of all the lines and to 
downfield shifts of nearly all the aromatic proton 
resonances. Here, also, no upfield shifts were 
observed. Since intercalation of aromatic groups 
into the helical structure of DNA results in upfield 
shifts of the protein aromatic amino acid 
resonances [14,151, intercalation can be excluded 
as a possible means of interaction of cro repressor 
with this 9 bp duplex. 
It is noteworthy that the signals of PheI, TyrI 
and TyrII, located inside the protein globule 191, 
do not shift upon complex formation (fig.2), in- 
dicating that there is no remarkable change in the 
environment of these residues and in 
3-dimensional structure of cro repressor upon 
complex formation. 
The most interesting results of our studies on the 
complex of cro repressor with 9 bp duplex are the 
changes which take place in positions of TyrIII and 
His-35 resonances (fig.1 and 2). TyrIII, which is 
the only tyrosine residue accessible to the solvent 
[9], is involved in interactions with the DNA 
duplex. The chemical shifts of ortho- and meta- 
proton resonances of TyrIII in the free protein are 
nearly identical (although measured in a mixture 
D20/hexafluoroisopropanol; 4 : 1, v/v) to those of 
tyrosine signals in the a-helical synthetic peptide 
corresponding to the fragment 26-39 of cro 
repressor [16]. On the other hand, the a-helical 
structure of the segment 26-37 in the protein 
polypeptide chain was predicted theoretically [17] 
and found in the crystal [5]. As was shown, the 
structure of cro repressor in solution is similar to 
that in the crystal [ 181. Therefore, according to the 
data of X-ray structure analysis [5] and taking into 
account that TyrIII is the only exposed tyrosine 
residue in the protein [9], we can conclude that this 
tyrosine is Tyr-26. 
It is evident from fig.1 and 2 that histidine-35 
also is involved in interactions with the 9 bp 
duplex. An increase in the pK of His-35 imidazole 
in the complex shows that a negative charge is 
located near the imidazole. Such a charge appears 
to come from the internucleotide phosphate group 
in the duplex. As demonstrated in [19], the 
distance between the imidazole and the charge 
located near it can be represented as a function of 
ApK, the local dielectric constant of the medium 
and the remoteness of the cycle from the protein 
surface. Under our experimental conditions, this 
distance may roughly be estimated as 5 A. 
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Tyr-26 and His-35 are located in the same a- 
helical region (as) which, as proposed from X-ray 
analysis of the free protein [5], is involved in 
specific interaction of cro repressor with 033. Our 
NMR data provide direct support for this model of 
cro repressor-DNA complex. 
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